Found: 5
Select item for more details and to access through your institution.
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1139980
- By:
- Publication type:
- Article
A TAT-conjugated peptide inhibitor of polo-like kinase 1 for in vivo tumor imaging.
- Published in:
- Journal of Analytical Science & Technology, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1186/s40543-019-0187-z
- By:
- Publication type:
- Article
Amphiphilic Triazine Polymer Derivatives as Antibacterial And Anti-atopic Agents in Mice Model.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51561-7
- By:
- Publication type:
- Article
Synthesis and evaluation of small molecule-based derivatives as inhibitors of polo-box domain of polo-like kinase-1.
- Published in:
- Journal of Analytical Science & Technology, 2023, v. 14, n. 1, p. 1, doi. 10.1186/s40543-023-00411-3
- By:
- Publication type:
- Article
Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea.
- Published in:
- Infection & Chemotherapy, 2023, v. 55, n. 1, p. 99, doi. 10.3947/ic.2022.0132
- By:
- Publication type:
- Article